An investment of £50,000 per flagship area is anticipated with the aim of supporting a post-doc for two years, in combination with matched funding from other BRC themes (III & Cardiovascular Diseases).
Assuming successful review in 2020, there will be a chance for projects to be extended until the end of the current BRC cycle (March 2022).
Please note that the NIHR policy precludes funding animal research.
Completed application forms should be sent to Tina Osadolor (theme Operations Manager) at t.osadolor@ucl.ac.uk by 5pm, Friday 8 February 2019.
The BRC expects projects to:
- focus on development and translation of engineering and imaging technology with application in healthcare
- involve clear clinical-engineering collaboration with strong PI involvement from both sides
- have clear translational impact within the timeframe of the current BRC, i.e. realistic translation from basic science to first-in-man and/or implementation in the NHS in the next 2-3 years. We may consider compelling cases for longer-term ideas that have the potential to become a flagship HE&I topic in the next BRC
- include a clear plan for follow-on or supplemental external funding
- prioritise applications that have matched funding, from other BRC themes or elsewhere, thereby extending the roughly £50,000 investment for two years
- prioritise projects that do not require new recruitment, i.e. already have researchers in place to execute the work
- support relatively few new initiatives focussed on cancer imaging and neuroimaging, since these topics are strongly represented already within the HE&I theme portfolio. However, we do not rule out supporting compelling cases.
Please note:
- Costs are primarily for personnel, but may include modest imaging, manufacturing, or other engineering costs.
- Successful applicants will be required to submit both annual and final reports summarising outcomes and impact of the BRC support and keep the theme board informed of progress and outcomes.
In this call, awards will be made by competition and will be reviewed by the HE&I theme board. Expert review will be sought where needed.
Investigators are expected to acknowledge the BRC in all publications. Please see here for recommended wording.
